Thank you to the FBomb Angels for a meaningful investment that supports our mission to transform health equity and sepsis detection through our VitalO₂ monitor. We are the health equity change we want to see in the world. This new investment builds on the $2.5 million in venture capital and private investments already raised, alongside more than $4 million in non-dilutive funding. It’s a testament to the growing confidence in Opticyte’s vision and potential, driven by our VitalO₂ monitor that we believe will revolutionize healthcare and save lives.
New Investment from FBomb Angels featuring Opticyte
